Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annmarie Bosco

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Internal Medicine Journal|January 14, 2026
Early de-escalation of broad-spectrum antibiotic therapy in febrile neutropeniaAlyssa Pradhan, Annmarie Bosco, Justin Beardsley, et al.
Clinical Nuclear Medicine|July 27, 2019
Concomitant Prostate Carcinoma and Follicular Lymphoma: "Flip-Flop" Appearances on PSMA and FDG PET/CT ScansNattakorn Dhiantravan, Elizabeth Hovey, Annmarie Bosco, et al.
Transfusion|January 28, 2009
An autoanti-Kp b immunoglobulin M that simulates antigen suppressionAnnmarie Bosco, Anargyros Xenocostas, Jeff Kinney, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 9, 2024
Characterising vincristine-induced peripheral neuropathy in adults: symptom development and long-term persistent outcomesTiffany Li, Terry Trinh, Annmarie Bosco, et al.
Journal of Pain and Symptom Management|August 3, 2019
Optimizing Clinical Screening for Chemotherapy-Induced Peripheral NeuropathyJ Matt McCrary, David Goldstein, Terry Trinh, et al.
Internal Medicine Journal|April 14, 2022
VEXAS syndrome: lessons learnt from an early Australian case seriesSadia Islam, Taylor Cullen, Daniel Sumpton, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
Balance Deficits and Functional Disability in Cancer Survivors Exposed to Neurotoxic Cancer TreatmentsJ Matt McCrary, David Goldstein, Terry Trinh, et al.
Internal Medicine Journal|May 30, 2026
Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman diseaseDipti Talaulikar, Jun Yen Ng, Adam Bryant, et al.
Asia-Pacific Journal of Clinical Oncology|March 23, 2026
Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant-Ineligible Newly Diagnosed Myeloma: An Australian Real-World, Multicenter StudySamantha Kurniawan, Angela Hwang, Nicole Wong Doo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 11, 2025
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert PanelArsene M Mekinian, Sophie Georgin-Lavaille, Marcela A Ferrada, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Internal Medicine Journal|January 14, 2026
Early de-escalation of broad-spectrum antibiotic therapy in febrile neutropeniaAlyssa Pradhan, Annmarie Bosco, Justin Beardsley, et al.
Clinical Nuclear Medicine|July 27, 2019
Concomitant Prostate Carcinoma and Follicular Lymphoma: "Flip-Flop" Appearances on PSMA and FDG PET/CT ScansNattakorn Dhiantravan, Elizabeth Hovey, Annmarie Bosco, et al.
Transfusion|January 28, 2009
An autoanti-Kp b immunoglobulin M that simulates antigen suppressionAnnmarie Bosco, Anargyros Xenocostas, Jeff Kinney, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 9, 2024
Characterising vincristine-induced peripheral neuropathy in adults: symptom development and long-term persistent outcomesTiffany Li, Terry Trinh, Annmarie Bosco, et al.
Journal of Pain and Symptom Management|August 3, 2019
Optimizing Clinical Screening for Chemotherapy-Induced Peripheral NeuropathyJ Matt McCrary, David Goldstein, Terry Trinh, et al.
Internal Medicine Journal|April 14, 2022
VEXAS syndrome: lessons learnt from an early Australian case seriesSadia Islam, Taylor Cullen, Daniel Sumpton, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
Balance Deficits and Functional Disability in Cancer Survivors Exposed to Neurotoxic Cancer TreatmentsJ Matt McCrary, David Goldstein, Terry Trinh, et al.
Internal Medicine Journal|May 30, 2026
Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman diseaseDipti Talaulikar, Jun Yen Ng, Adam Bryant, et al.
Asia-Pacific Journal of Clinical Oncology|March 23, 2026
Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant-Ineligible Newly Diagnosed Myeloma: An Australian Real-World, Multicenter StudySamantha Kurniawan, Angela Hwang, Nicole Wong Doo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 11, 2025
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert PanelArsene M Mekinian, Sophie Georgin-Lavaille, Marcela A Ferrada, et al.
Pageof 1